Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
ILS | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 342 | 449 | 382 | 343 | 511 | 1,105 | 894 | 849 | 1,040 | 1,523 | | 1,523 |
% Growth | NA | 31.4% | -15.0% | -10.1% | 48.8% | 116.4% | -19.1% | -5.0% | 22.5% | 46.4% | | |
| | | | | | | | | | | | |
Cost of Revenue | (306) | (385) | (339) | (311) | (449) | (976) | (758) | (711) | (851) | (1,175) | | (1,175) |
Gross Profit | 36 | 65 | 43 | 33 | 62 | 130 | 136 | 138 | 189 | 348 | | 348 |
% Revenue | 10.4% | 14.4% | 11.2% | 9.5% | 12.2% | 11.7% | 15.3% | 16.3% | 18.2% | 22.8% | | 22.8% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (6) | (8) | (15) | (8) | (15) | (16) | (11) | (20) | (19) | (27) | | (27) |
General and Admin | (17) | (18) | (25) | (32) | (27) | (24) | (24) | (28) | (30) | (47) | | (47) |
Other Inc / (Exp) | 44 | (0) | 13 | 28 | 16 | 17 | 83 | 121 | 108 | 229 | | 229 |
Total Operating Exp | 21 | (26) | (27) | (13) | (26) | (23) | 48 | 73 | 59 | 156 | | 156 |
| | | | | | | | | | | | |
Operating Income | 57 | 39 | 15 | 20 | 36 | 107 | 184 | 211 | 248 | 503 | | 503 |
% Revenue | 16.5% | 8.7% | 4.0% | 5.9% | 7.1% | 9.7% | 20.6% | 24.9% | 23.9% | 33.0% | | 33.0% |
| | | | | | | | | | | | |
Interest Expense | 1 | (16) | (17) | (25) | (36) | (50) | (39) | (38) | (95) | (114) | | (114) |
Pre-tax Income | 58 | 22 | (2) | (5) | (0) | 57 | 144 | 173 | 153 | 389 | | 389 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (2) | (3) | (11) | (2) | 4 | (15) | (31) | (32) | (35) | (29) | | (29) |
Net Income to Company | 56 | 20 | (13) | (7) | 3 | 42 | 114 | 141 | 118 | 360 | | 360 |
% Margin | 16.3% | 4.4% | -3.3% | -2.1% | 0.7% | 3.8% | 12.7% | 16.6% | 11.4% | 23.7% | | 23.7% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (0) | (1) | (0) | | (0) |
Net Income to Stockholders | 56 | 20 | (13) | (7) | 4 | 42 | 114 | 141 | 118 | 360 | | 360 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 56 | 20 | (13) | (7) | 4 | 42 | 114 | 141 | 118 | 360 | | 360 |
% Margin | 16.3% | 4.4% | -3.3% | -2.1% | 0.7% | 3.8% | 12.7% | 16.6% | 11.3% | 23.7% | | 23.7% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.39 | 0.14 | (0.08) | (0.04) | 0.02 | 0.19 | 0.47 | 0.55 | 0.45 | 1.29 | | 1.29 |
Diluted EPS (Continuing Ops) | 0.36 | 0.13 | (0.08) | (0.04) | 0.02 | 0.19 | 0.47 | 0.55 | 0.45 | 1.29 | | 1.29 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 141.21 | 142.78 | 157.64 | 194.83 | 204.06 | 218.06 | 242.54 | 256.20 | 260.29 | 278.23 | | 278.23 |
WA Diluted Shares Out. | 153.97 | 152.72 | 157.64 | 194.83 | 204.06 | 225.67 | 242.66 | 256.94 | 260.95 | 280.11 | | 280.11 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 58 | 22 | (2) | (5) | (0) | 57 | 144 | 173 | 153 | 389 | | 389 |
Addback: Net Interest Expense | (1) | 16 | 17 | 25 | 36 | 50 | 39 | 38 | 95 | 114 | | 114 |
Addback: Other Non Operating Expenses, Total | (2) | (5) | (5) | (2) | (5) | (11) | (15) | (8) | (75) | (72) | | (72) |
Addback: Depreciation & Amortization | 0 | 0 | 1 | 1 | 3 | 4 | 4 | 3 | 4 | 6 | | 6 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | (5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (3) | 1 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | | 0 |
Addback: Asset Writedown | (13) | 5 | (10) | (42) | (11) | (7) | (57) | (79) | (35) | (85) | | (85) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (24) | 0 | 0 | 0 | 0 | 0 | 0 | (40) | 0 | (73) | | (73) |
Adjusted EBITDA | 13 | 39 | 2 | (23) | 23 | 93 | 115 | 94 | 144 | 280 | | 280 |
% Margin | 3.8% | 8.8% | 0.4% | -6.7% | 4.5% | 8.4% | 12.9% | 11.1% | 13.9% | 18.4% | | 18.4% |
| | | | | | | | | | | | |
Adjusted EBIT | 13 | 39 | 1 | (24) | 20 | 89 | 111 | 91 | 140 | 274 | | 274 |
% Margin | 3.7% | 8.7% | 0.2% | -7.0% | 4.0% | 8.0% | 12.5% | 10.7% | 13.5% | 18.0% | | 18.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 56 | 20 | (13) | (7) | 3 | 42 | 114 | 141 | 118 | 360 | | 360 |
Addback: Unusual Items | (42) | 5 | (10) | (42) | (11) | (7) | (57) | (112) | (34) | (158) | | (158) |
Less: Tax Benefit of Unusual Items (26%) | 11 | (1) | 3 | 11 | 3 | 2 | 15 | 29 | 9 | 41 | | 41 |
Adjusted Net Income | 25 | 24 | (20) | (38) | (5) | 37 | 71 | 58 | 93 | 244 | | 244 |
% Margin | 7.2% | 5.3% | -5.2% | -11.2% | -0.9% | 3.3% | 8.0% | 6.8% | 9.0% | 16.0% | | 16.0% |